Genre
- Journal Article
The present study demonstrates alterations in the regulation of matrix metalloproteinase-2 (MMP-2) expression in response to insulin like growth factor-1 (IGF-1) in a H-ras transformed cell line, C3, which is capable of metastasis formation. These changes in MMP-2 expression in response to IGF-1 treatment did not occur in either non-transformed parental 10 T1/2 cells or in H-ras transformed cells (NR3 cells) which are capable of benign tumour formation. IGF-1 treatment of C3 cells resulted in increased expression of MMP-2 gelatinolytic activity and increased expression of MMP-2 mRNA levels. The IGF-1 mediated alterations in MMP-2 mRNA levels were dependent upon de novo protein synthesis and independent of transcriptional events, but dependent upon post-transcriptional regulatory events. Most notably, IGF-1 can regulate MMP-2 mRNA expression in C3 cells through a mechanism involving MMP-2 message stabilization. This study demonstrates aspects of the temporal regulatory mechanisms of MMP-2 expression in response to insulin-like growth factor-1 in a H-ras transformed fibrosarcoma cell line capable of metastasis formation and thereby, provides further insight into the altered growth regulatory program associated with H-ras mediated cellular transformation and malignant progression.
St Michaels Hosp, Dept Lab Med & Pathobiol, Toronto, ON M5B 1A6, Canada. Univ Toronto, Toronto, ON, Canada.; Hurta, RAR, St Michaels Hosp, Dept Lab Med & Pathobiol, 1-001,East Annex,38 Shuter St, Toronto, ON M5B 1A6, Canada.
DORDRECHT; SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
KLUWER ACADEMIC PUBL
PT: J; CR: AHO S, 1997, EUR J BIOCHEM, V247, P503 CHAMBERS AF, 1993, CRIT REV ONCOGENESIS, V4, P95 CHAMBERS AF, 1997, J NATL CANCER I, V89, P1260 CORCORAN ML, 1996, ENZYME PROTEIN, V49, P7 CRAWFORD HC, 1996, ENZYME PROTEIN, V49, P20 EGAN SE, 1987, MOL CELL BIOL, V7, P830 GIAMBERNARDI TA, 1998, MATRIX BIOL, V16, P483 HUHTALA P, 1991, J BIOL CHEM, V266, P16485 HURTA RAR, 1996, J CELL BIOCHEM, V60, P572 LONG L, 1998, CANCER RES, V58, P3242 NAKANO A, 1995, J NEUROSURG, V83, P298 OVERALL CM, 1989, CONNECT TISSUE RES, V20, P289 RAWDANOWICZ TJ, 1994, J CLIN ENDOCR METAB, V79, P530 SAMUEL SK, 1992, EMBO J, V11, P1599 VINCENTI MP, 1998, BIOCHEM J 1, V331, P341 WITTY JP, 1995, MOL BIOL CELL, V16, P1287 WRIGHT JA, 1990, ANTICANCER RES, V10, P1247; NR: 17; TC: 9; J9: MOL CELL BIOCHEM; PG: 6; GA: 471UY
Source type: Electronic(1)
Language
- English
Subjects
- genes
- malignant progression
- H-ras
- IGF-1
- FIBROBLASTS
- Cell Biology
- matrix metalloproteinase-2
- METASTASIS
- INTERSTITIAL COLLAGENASE